Australian And New Zealand Intensive Care Research Centre

This large trial aims to find the best way to replace a key blood clotting factor (fibrinogen) in adults with severe traumatic injuries and major bleeding. It will compare a fast-acting powder (fibrinogen concentrate) that can be mixed at the bedside against the standard frozen b…

This trial is testing whether two existing bone-strengthening drugs, denosumab or zoledronic acid, can prevent bone loss in older adults who have survived a serious illness requiring intensive care. It will involve 450 women aged 50+ and men aged 70+ who spent more than a day in …